 UroToday has as it's stated mission on it's website to create a quality, global online publication providing accurate and timely education that is clinically relevant in the practice of Urology. UroToday is developed by world-class leaders in Urology committed to delivering translational science into the realities of medical practice.For the latest news, for what urologists and academics are sharing with each other, please check here often.
Prostate Cancer
Beyond the Abstract - Finnish Multicenter
Study Comparing Intermittent to Continuous Androgen Deprivation for
Advanced Prostate Cancer: Interim Analysis of Prognostic Markers Affecting
Initial Response to Androgen Deprivation
BERKELEY, CA (UroToday.com) - The FinnProstate Study VII
(FPVII) is conducted as an open-label, randomized, controlled,
parallel-group, multicenter clinical trial comparing intermittent and
continuous ADT in patients with advanced PC. read
more
Beyond the Abstract - ProsCan for Men:
Randomised Controlled Trial of a Decision Support Intervention for Men
with Localised Prostate Cancer
BERKELEY, CA (UroToday.com) - With advances in treatment
for prostate cancer and the often deleterious side-effects of treatment,
newly diagnosed men are faced with difficult treatment decisions.
read
more
Beyond the Abstract - MR-Guided Biopsy of
the Prostate: An Overview of Techniques and a Systematic
Review
BERKELEY, CA (UroToday.com) -
Next to digital rectal examination and PSA level, biopsy of the prostate
is an essential procedure for determining optimal treatment. read
more
|
All material
provided on the pages located in the Vibrance Network domains are provided for educational purposes only and are not intended to be a substitute for professional medical advice. Always consult your own physician
regarding the applicability of any information on this site with respect to your symptoms or medical condition.
Using this site assumes you have read and agreed to the disclaimer. © Copyright 2008. Vibrance Associates,
LLC.
All Rights
Reserved.